Megamox Bid

Amoxicillin, the active ingredient in Megamox Bid, is a penicillin beta‑lactam antibiotic presented as a tablet for oral administration. Combined with clavulanic acid, it inhibits bacterial cell‑wall synthesis and protects amoxicillin from beta‑lactamase degradation, making it effective for treating a range of bacterial infections in both adult and pediatric patients.

GNH USA supplies Megamox Bid as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, offering reliable sourcing, regulatory support and consistent product quality across global markets.

Megamox Bid, a penicillin beta‑lactam antibacterial, is used to treat infections caused by susceptible bacteria in various organ systems.

Acute sinusitis: reduces bacterial load and alleviates sinus inflammation. Acute otitis media: clears middle‑ear infection and improves hearing. Community‑acquired pneumonia: eradicates pulmonary pathogens and resolves respiratory symptoms. Uncomplicated urinary tract infections: eliminates uropathogens and relieves dysuria. Skin and soft‑tissue infections: treats cellulitis and other bacterial skin conditions.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Diarrhea: loose stools, often self‑limiting. - Rash: mild skin erythema or itching. - Headache: transient cranial discomfort.

Serious or Rare Side Effects: - Anaphylaxis: severe, potentially life‑threatening allergic reaction. - Clostridioides difficile‑associated colitis: severe diarrhea with abdominal pain. - Hepatic enzyme elevation: possible liver function abnormalities. - Stevens‑Johnson syndrome: rare, severe mucocutaneous eruption.

Before prescribing, consider the following precautions: - Assess allergy history: avoid in patients with known penicillin hypersensitivity. - Monitor renal function: dose adjustment may be required in renal impairment. - Use with caution in hepatic disease: consider periodic liver‑function testing. - Evaluate pregnancy risk: category B, use only if benefits outweigh potential risks. - Store at ambient temperature: keep below 25°C in the original pack, protect from moisture.

Megamox Bid may interact with several medicines.

Major Interactions (Avoid): - Probenecid: reduces renal excretion, increasing amoxicillin levels. - Oral contraceptives: may decrease hormonal efficacy, increasing pregnancy risk. - Allopurinol: heightened risk of skin rash. - Methotrexate: increased toxicity due to reduced clearance.

Moderate Interactions (Monitor Closely): - Warfarin: potential enhancement of anticoagulant effect, monitor INR. - Phenytoin: may lower plasma concentrations, monitor seizure control.